BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | BAUSCH | ||
3.75%;EQ 1.2% BASE | |||
Yes | Yes | ||
2029-Aug-05 | Expired | ||
None | None | ||
None | No | ||
ONEXTON is a combination of clindamycin phosphate (a lincosamide antibacterial) and benzoyl peroxide indicated for the topical treatment of acne vulgaris in patients 12 years or older. |
2 | 1 | 1 |
Total Other Developers | 3 |
---|
Drugs with Suitability | No |
---|
3.75%;EQ 1.2% BASE | ** | ** | Up | - | 1 |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|---|---|---|---|---|
****** | ******* ****** | ******* ****** *************** *** | *********** | * ********* ***, *******, *******, ****** (***) | *** |
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com